Can all patients with COPD use the correct inhalation flow with all inhalers and does training help? RAM Al-Showair, WY Tarsin, KH Assi, SB Pearson, H Chrystyn Respiratory medicine 101 (11), 2395-2401, 2007 | 282 | 2007 |
Emitted dose estimates from Seretide® Diskus® and Symbicort® Turbuhaler® following inhalation by severe asthmatics WY Tarsin, SB Pearson, KH Assi, H Chrystyn International journal of pharmaceutics 316 (1-2), 131-137, 2006 | 102 | 2006 |
In-Vitro Intra- and Inter-Inhaler Flow Rate-Dependent Dosage Emission from a Combination of Budesonide and Eformoterol in a Dry Powder Inhaler W Tarsin, KH Assi, H Chrystyn Journal of aerosol medicine 17 (1), 25-32, 2004 | 95 | 2004 |
Microemulsion high performance liquid chromatography (MELC) method for the determination of terbutaline in pharmaceutical preparation MS Althanyan, KH Assi, BJ Clark, J Hanaee Journal of pharmaceutical and biomedical analysis 55 (3), 397-402, 2011 | 54 | 2011 |
Development and validation of HPLC method for the determination of tobramycin in urine samples post-inhalation using pre-column derivatisation with fluorescein isothiocyanate M Mashat, H Chrystyn, BJ Clark, KH Assi Journal of Chromatography B 869 (1-2), 59-66, 2008 | 53 | 2008 |
Dose emission and aerodynamic characterization of the terbutaline sulphate dose emitted from a Turbuhaler at low inhalation flow ME Abdelrahim, KH Assi, H Chrystyn Pharmaceutical development and technology 18 (4), 944-949, 2013 | 49 | 2013 |
Relative bioavailability of terbutaline to the lung following inhalation, using urinary excretion ME Abdelrahim, KH Assi, H Chrystyn British journal of clinical pharmacology 71 (4), 608-610, 2011 | 46 | 2011 |
High performance liquid chromatography assay method for simultaneous quantitation of formoterol and budesonide in Symbicort Turbuhaler KH Assi, W Tarsin, H Chrystyn Journal of pharmaceutical and biomedical analysis 41 (1), 325-328, 2006 | 45 | 2006 |
Aerodynamic characteristics of a dry powder inhaler at low inhalation flows using a mixing inlet with an Andersen Cascade Impactor DK Nadarassan, KH Assi, H Chrystyn European journal of pharmaceutical sciences 39 (5), 348-354, 2010 | 41 | 2010 |
Smart nanocrystals of artemether: fabrication, characterization, and comparative in vitro and in vivo antimalarial evaluation SMH Shah, F Ullah, S Khan, SMM Shah, M de Matas, Z Hussain, ... Drug design, development and therapy, 3837-3850, 2016 | 38 | 2016 |
Determination of organic acid drug counter-ions by capillary electrophoresis KD Altria, KH Assi, SM Bryant, BJ Clark Chromatographia 44, 367-371, 1997 | 37 | 1997 |
Determination of trace enantiomeric impurities in chiral compounds by capillary electrophoresis with uncoated, cationic, anionic and neutral surface modified capillaries KH Assi, AM Abushoffa, KD Altria, BJ Clark Journal of Chromatography A 817 (1-2), 83-90, 1998 | 35 | 1998 |
Validation of high-performance liquid chromatography assay for quantification of formoterol in urine samples after inhalation using UV detection technique DK Nadarassan, H Chrystyn, BJ Clark, KH Assi Journal of Chromatography B 850 (1-2), 31-37, 2007 | 33 | 2007 |
Development and evaluation of nanoemulsion and microsuspension formulations of curcuminoids for lung delivery with a novel approach to understanding the aerosol performance of … RC Gopalan, M Najafzadeh, MA Mohammad, D Anderson, A Paradkar, ... International journal of pharmaceutics 557, 254-263, 2019 | 29 | 2019 |
Development and validation of micro emulsion high performance liquid chromatography (MELC) method for the determination of nifedipine in pharmaceutical preparation MKH Al-Jammal, Y Al Ayoub, KH Assi | 21 | 2015 |
Aerodynamic dose emission characteristics of dry powder inhalers using an Andersen Cascade Impactor with a mixing inlet: The influence of flow and volume SI Yakubu, KH Assi, H Chrystyn International journal of pharmaceutics 455 (1-2), 213-218, 2013 | 21 | 2013 |
The different resistance of dry powder inhalers (DPIs) A KH Am J Respir Crit Care Med 163, A443, 2001 | 17 | 2001 |
In vitro aerodynamic characterization of the dose emitted during nebulization of tobramycin high strength solution by novel and jet nebulizer delivery systems M Mashat, BJ Clark, KH Assi, H Chrystyn Pulmonary Pharmacology & Therapeutics 37, 37-42, 2016 | 16 | 2016 |
Development and optimisation of inhalable EGCG nano-liposomes as a potential treatment for pulmonary arterial hypertension by implementation of the design of experiments approach F Haddad, N Mohammed, RC Gopalan, YA Ayoub, MT Nasim, KH Assi Pharmaceutics 15 (2), 539, 2023 | 12 | 2023 |
In vitro characterization of the emitted dose from the foradil aerolizer to identify the influence of inhalation flow, inhilation volume and the number of inhalations per dose A Alaboud, KH Assi, H Chrystyn Respiratory drug delivery 3, 803-806, 2010 | 12 | 2010 |